Can Wang, MD, PhD

Chongqing university cancer hospital

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 27

2246 - Clinical Study of Hypofractionated Radiotherapy Combined with Temozolomide and Bevacizumab In the Treatment of Newly Diagnosed Postoperative Glioblastoma

03:00pm - 04:00pm ET

Sep 27

2247 - Comparative Study of Immunotherapy Combined with High-Dose vs. Standard-Dose Concurrent Chemoradiotherapy for Locally Advanced Cervical Esophageal Squamous Cell Carcinoma

03:00pm - 04:00pm ET